Important Notice: Limited Web Access Dec 16 to 18, 2016

AIChE will undertake a routine upgrade of our digital infrastructure over the weekend of December 16-18, 2016. During this period access to certain areas of the website will be limited. Additional information will be forthcoming shortly.

Mr. Steven M. Weisser

Mr. Steven M. Weisser

Senior Scientist
GlaxoSmithKline

Steven Weisser is a Senior Scientist in the Biopharmaceutical Development group at GlaxoSmithKline, where he works on downstream processing of therapeutic proteins.  In this role, he is responsible for developing and characterizing purification processes and transferring them from the lab scale to manufacturing facilities for GMP production of a biopharmaceutical product.

Prior to joining GSK, Steven worked in the process development group at ImClone Systems Incorporated, where he developed and transferred purification processes for early-phase and commercially approved monoclonal antibodies.

Steven received his B.S. in Biochemistry from Lehigh University.